According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain. These conditions can affect balance, movement, speech, and respiratory and cardiac functions. They can be inherited or be of unknown etiology. Neurodegenerative diseases are incurable and are severely debilitating. They result in progressive degeneration of nerve cells, causing them to die eventually. These diseases cause ataxia and dementia in people, which can have a serious impact on the mental health of patients. Some examples of neurodegenerative diseases are Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and epilepsy. Huntington’s disease and amyotrophic lateral sclerosis are rare diseases, unlike Alzheimer’s disease and Parkinson’s disease which have a high degree of prevalence.
Read more details at: http://www.bigmarketresearch.com/global-neurodegenerative-diseases-2015-2019-market
Analysts forecast the global neurodegenerative diseases market to grow at a CAGR of 4.77 percent over the period 2014-2019.
Covered in this report
This report covers the present scenario and the growth prospects of the global neurodegenerative diseases market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases.
The market includes data from the sales of various drugs used in the treatment of:
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Huntington's Disease
• Amyotrophic Lateral Sclerosis
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global neurodegenerative diseases market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios. In addition, it discusses the major drivers that...